Ameluz-based photodynamic therapy achieved higher clearance rates in superficial basal cell carcinoma compared to placebo, with significant clinical and histological results. The study involved 187 ...

"Cutaneous T-cell lymphoma- Pipeline Insight, 2024" report outlays comprehensive insights of ... HyBryteT (synthetic hypericin or SGX301) is a novel, first-in-class, photodynamic therapy utilizing ...

PRINCETON, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: SNGX) (“Soligenix” or the “Company”) a late-stage biopharmaceutical company focused on developing and commercializing products to treat ...